299
Views
12
CrossRef citations to date
0
Altmetric
Review

Psychometric Properties of Cognitive Assessment in Amyotrophic Lateral Sclerosis: A Systematic Review

, ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon
Pages 181-194 | Published online: 22 Sep 2020
 

Abstract

Purpose

We aimed to list all tests used to assess cognitive change in patients with amyotrophic lateral sclerosis (ALS) and to provide a descriptive synthesis of the psychometric properties of tests that were evaluated in a population of ALS patients.

Materials and Methods

The protocol is registered in PROSPERO (ID: CRD42017055603). We systematically search for literature in 11 databases. Full-text articles, in any language, with original research were included. All included articles were scrutinised by two independent authors. Disagreement was resolved by consensus. The framework of Lezak informed conceptualises of the tests identified. To evaluate methodological quality, we used the Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN). Data were synthesised using criteria proposed by the Cochrane Back Review Group.

Results

Of 319 included articles, 46 articles reported information on the psychometric properties of cognitive tests used in patients with ALS. We found that the highest level of evidence was supported for the Reading the Mind in the Eye Test (RME), Addenbrooke’s Cognitive Evaluation (ACE) and Frontal Assessment Battery (FAB). Moderate level of evidence was found for the screening tests; Edinburgh Cognitive and Behavioural ALS Screen (ECAS) and the Montreal Cognitive Assessment (MoCA).

Conclusion

The screening test, ECAS and the social cognition test, RME, may have some advantages over other tests that have been used for assessing cognitive change in ALS patients. Recommendations of ALS-specific tests with sound psychometric properties are urgently needed.

Acknowledgments

The authors thank Professor Hans Lund at the Western Norway University of Applied Sciences, Bergen for sharing his extensive experience in conducting systematic reviews and generously providing advice along the way.

Disclosure

Tina Taule reports three of the authors of this review are involved in the validation of the Norwegian version of the ECAS. The authors report no other potential conflicts of interest for this work. This work was funded by grants from the Western Regional Norwegian Health Authority [grant number: 912,158, 2017].